Fox Chase Cancer Center Welcomes Dr. Marcus Messmer

PMarcus Messmer, MD, joins the Department of Hematology/Oncology
PMarcus Messmer, MD, joins the Department of Hematology/Oncology

PHILADELPHIA (July 1, 2021) - Fox Chase Cancer Center is pleased to announce the hiring of Marcus Messmer, MD, who will join the Department of Hematology/Oncology as an assistant professor.

Messmer will begin his tenure at Fox Chase following the completion of his fellowship in medical oncology at Johns Hopkins University, where he became chief oncology fellow in 2020. In that role, Messmer developed a comprehensive humanism curriculum for oncology fellows, which included initiatives to address racism in medicine.

He graduated from Johns Hopkins University Medical School and was inducted into the Alpha Omega Alpha Honor Society. Prior to his medical oncology fellowship, Messmer was an intern and then resident in internal medicine at Johns Hopkins. He also served as a hospitalist in the oncology critical care unit there.

He is a member-in-training of the American Society of Clinical Oncology (ASCO). In 2020, he won a merit award during the ASCO Annual Meeting for his work on studying large granular lymphocytosis after bone marrow transplantation. A particular research interest of Messmer is the study of lymphoma; he has been developing multiple clinical trial concepts for patients with the condition.

Messmer will start at Fox Chase on July 12.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text